当前位置:首页 - 行情中心 - 小方制药(603207) - 财务分析 - 现金流量表

小方制药

(603207)

  

流通市值:13.63亿  总市值:40.38亿
流通股本:5460.29万   总股本:1.62亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金311,313,497.45152,687,702.87562,228,319.24416,771,775.69
  收到的税费返还3,024,551.46-2,237,093.2185,619.74
  收到其他与经营活动有关的现金456,086.932,134,423.831,575,392.682,397,923.32
  经营活动现金流入小计314,794,135.84154,822,126.7566,040,805.13419,255,318.75
  购买商品、接受劳务支付的现金105,703,886.4559,176,695.59191,833,932.62143,013,356.69
  支付给职工以及为职工支付的现金45,847,810.7222,350,597.7880,796,240.246,896,555.83
  支付的各项税费42,449,107.3518,885,091.9988,358,064.7165,190,948.97
  支付其他与经营活动有关的现金23,058,054.499,078,514.7444,255,918.1230,217,739.46
  经营活动现金流出小计217,058,859.01109,490,900.1405,244,155.65285,318,600.95
  经营活动产生的现金流量净额97,735,276.8345,331,226.6160,796,649.48133,936,717.8
二、投资活动产生的现金流量:
  收回投资收到的现金147,000,0003,000,000923,000,000553,000,000
  取得投资收益收到的现金2,281,5001,730,208.334,138,663.883,660,316.66
  处置固定资产、无形资产和其他长期资产收回的现金净额--110,619.47110,619.47
  投资活动现金流入小计149,281,5004,730,208.33927,249,283.35556,770,936.13
  购建固定资产、无形资产和其他长期资产支付的现金61,620,231.1956,097,176.7854,240,215.6449,140,746.75
  投资支付的现金324,144,000303,000,000567,000,000420,000,000
  投资活动现金流出小计385,764,231.19359,097,176.78621,240,215.64469,140,746.75
  投资活动产生的现金流量净额-236,482,731.19-354,366,968.45306,009,067.7187,630,189.38
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,446,777.153,320,621.418,382,705.998,382,705.99
  收到其他与筹资活动有关的现金7,662,756.66,354,357.21,119,069.581,776,039.74
  筹资活动现金流入小计9,109,533.759,674,978.619,501,775.5710,158,745.73
  分配股利、利润或偿付利息支付的现金19,725,031.12-353,231,927.4240,839,950.5
  支付其他与筹资活动有关的现金291,00040,5005,735,8205,170,000
  筹资活动现金流出小计20,016,031.1240,500358,967,747.4246,009,950.5
  筹资活动产生的现金流量净额-10,906,497.379,634,478.61-349,465,971.83-235,851,204.77
五、现金及现金等价物净增加额-149,653,951.73-299,401,263.24117,339,745.36-14,284,297.59
  加:期初现金及现金等价物余额544,189,596.35544,189,596.35426,849,850.99426,849,850.99
  期末现金及现金等价物余额394,535,644.62244,788,333.11544,189,596.35412,565,553.4
补充资料:
  净利润105,550,017.8-207,489,677.18-
  资产减值准备498.86-183,048.19-
  固定资产和投资性房地产折旧1,223,139.5-1,928,961.94-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧1,223,139.5-1,928,961.94-
  无形资产摊销793,794.78-9,350.76-
  长期待摊费用摊销--99,144.12-
  递延收益摊销---12,857.16-
  处置固定资产、无形资产和其他长期资产的损失5,641.59--110,619.47-
  财务费用-1,869,805.94--532,028.58-
  递延所得税-329,407.45--1,321,536.72-
  其中:递延所得税资产减少-322,978.87--1,321,536.72-
    递延所得税负债增加-6,428.58---
  存货的减少7,799,700.77--24,161,113.86-
  经营性应收项目的减少-11,382,618.92--48,716,490.55-
  经营性应付项目的增加-6,327,300.72-20,425,168.79-
  现金的期末余额394,535,644.62-544,189,596.35-
  减:现金的期初余额544,189,596.35-426,849,850.99-
  现金及现金等价物的净增加额-149,653,951.73-117,339,745.36-
公告日期2026-08-272026-04-282026-04-282025-10-25
审计意见(境内)标准无保留意见
TOP↑